Page 83 | Certara

Press Release

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

PRINCETON, N.J.— July 13, 2023-- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today…

CertaraJuly 13, 2023

Poster

Exploring Amyloid Antibodies Treatment Guidelines in Alzheimer’s Disease Using A Quantitative Systems Pharmacology Approach

CertaraJuly 12, 2023

On-Demand Webinar

AAPS eChalk talk: FDA Modernization Act – What Does it Mean for Pharmaceutical Scientists?

Historically, the FDA has required drug discovery and development programs to include animal testing. With the…

CertaraJuly 12, 2023

Brochure

Introduction to compound summaries and overview of the Simcyp™ compound library

CertaraJuly 11, 2023

Conference

Alzheimer’s Association International Conference (AAIC®)

–

CertaraJuly 7, 2023

White Paper

Understanding the Impact of FDA Modernization Act 2.0 on Drug Development

Learn how the FDA Modernization Act 2.0 will change the drug development landscape by allowing…

CertaraJuly 6, 2023

On-Demand Webinar

How QSP brings insights and accelerates bispecific antibody drug development

Wednesday, August 9th 2023 More than 50 bispecific antibodies are in oncology clinical development with…

CertaraJune 29, 2023

On-Demand Webinar

Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease

Meet the Quantitative Systems Pharmacology (QSP) experts and view applications in Inflammatory Bowel Disease (IBD)…

CertaraJune 29, 2023

On-Demand Webinar

Project Optimus: Transforming oncology drug development

CertaraJune 29, 2023

Fact Sheet

QSP Fact Sheet: Pioneering the Field of Quantitative Systems Pharmacology

CertaraJune 28, 2023

Certara to Report Second Quarter 2023 Financial Results on August 9th, 2023

Exploring Amyloid Antibodies Treatment Guidelines in Alzheimer’s Disease Using A Quantitative Systems Pharmacology Approach

AAPS eChalk talk: FDA Modernization Act – What Does it Mean for Pharmaceutical Scientists?

Introduction to compound summaries and overview of the Simcyp™ compound library

Alzheimer’s Association International Conference (AAIC®)

Understanding the Impact of FDA Modernization Act 2.0 on Drug Development

How QSP brings insights and accelerates bispecific antibody drug development

Quantitative Systems Pharmacology (QSP) Model Applications in Inflammatory Bowel Disease (IBD) and Alzheimer’s Disease

Project Optimus: Transforming oncology drug development

QSP Fact Sheet: Pioneering the Field of Quantitative Systems Pharmacology

Newsletter sign up

Quick links

Solutions

Contact